CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed
Drug / intervention
streptokinasedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00000507
NCT00000507Phase 3Completed
CompareCT.gov

Intravenous Streptokinase in Acute Myocardial Infarction

University of Washington·interventional·Posted Oct 28, 1999·Updated Feb 10, 2016

In Brief

A Phase 3 clinical trial evaluating streptokinase for Cardiovascular Diseases and 4 related conditions. Completed.

Detailed Summary

To determine whether the administration of intravenous streptokinase (SK) early in the course of acute, transmural myocardial infarction would limit myocardial damage.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCardiovascular Diseases, Coronary Disease, Heart Diseases, Myocardial Infarction, Myocardial Ischemia
Countries--
CollaboratorsNational Heart, Lung, and Blood Institute (NHLBI)

Timeline

Phase 3CompletedFinished
198319841985198619871988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedOct 28, 1999
Enrollment StartAug 1, 1983
Study CompletionOct 1, 1994
TodayJul 2, 2026
Posted 26.7 years ago

Interventions

streptokinasedrug